Smallpox Vaccine

Research from Oregon Health & Science University provides new data about smallpox vaccines

Smallpox Vaccine Library Library Home This article was published in Pharma Business Week, which you can subscribe to online.

"We compared cutaneous vaccinia responses in patients vaccinated in the distant past with vaccine-naive individuals using serial close-up photographs. The previously vaccinated group had a significantly reduced time course and milder cutaneous reactions," wrote E.L. Simpson and colleagues, Oregon Health & Science University.

The researchers concluded: "Vaccinated individuals appear to maintain clinically detectable immunity against vaccinia for at least 20 years after smallpox vaccination."

Simpson and colleagues published their study in the Journal of the American Academy of Dermatology (Cutaneous responses to vaccinia in individuals with previous smallpox vaccination. Journal of the American Academy of Dermatology, 2007;57(3):442-444).

For additional information, contact E.L. Simpson, Oregon Health Sciences University, Center Health & Healing CH16D, Dept. of Dermatology, 3303 SW Bond Avenue, Portland, OR 97239, USA.

The publisher's contact information for the Journal of the American Academy of Dermatology is: Mosby-Elsevier, 360 Park Avenue South, New York, NY 10010-1710, USA.

Keywords: United States, Portland, Immunization, Smallpox Vaccines, Vaccination, Oregon Health & Science University.

This article was prepared by Pharma Business Week editors from staff and other reports. Copyright 2007, Pharma Business Week via NewsRx.com.